Founded in 2000, Diverchim is a Small Molecule Drug Substance CDMO that specializes in complex chemistry. Diverchim offers premium services for the development and the manufacturing of small quantities APIs, from early phases to commercial. Our customers include pharma companies and emerging Biotechs involved in developing New Chemical Entities. We have a strong focus on high added-value APIs (rare diseases and orphan drugs, radiopharmaceuticals). Our capabilities include various cGMP manufacturing suites: small scale (mg to dozens of grams), kilolabs (up to a few kilos) and pilot plant (dozens of kilos).
Looking for a particular DIVERCHIM CDMO employee's phone or email?
The DIVERCHIM CDMO annual revenue was $6.2 million in 2026.
Francois MacArez is the CEO of DIVERCHIM CDMO.
40 people are employed at DIVERCHIM CDMO.
DIVERCHIM CDMO is based in Montataire, Hauts-de-France.
The NAICS codes for DIVERCHIM CDMO are [325, 3254, 32, 32541].
The SIC codes for DIVERCHIM CDMO are [283, 28].